Sort
25,944 grants matching “neurodegeneration”
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design
$494,761Nathan N Alder · University Of Connecticut Storrs · R01 · FY2023 · AG
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design
$494,761Nathan N Alder · University Of Connecticut Storrs · R01 · FY2024 · AG
First-in-class peptide therapeutics for mitochondrial disorders: molecular mechanism of action and optimization of design
$494,761Nathan N Alder · University Of Connecticut Storrs · R01 · FY2022 · AG
Role of Peripheral Inflammation in TBI Pathobiology
$494,716Pramod K Dash · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · NS
Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System
$494,693Marcie A Glicksman · Enclear Therapies, Inc. · R44 · FY2024 · NS
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease
$494,590Daniel S Ory · Washington University · R01 · FY2017 · NS
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease
$494,590Daniel S Ory · Washington University · R01 · FY2016 · NS
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease
$494,590Daniel S Ory · Washington University · R01 · FY2018 · NS
Novel Lysosomal Enzyme Deficient in Batten Disease
$494,355Peter Lobel · Rbhs-Robert Wood Johnson Medical School · R01 · FY2020 · NS
Brain Aging &Gene Expression Patterns Using Microarrays
$494,325University Of California Irvine · R01 · FY2003 · AG
Mechanism of antibody-mediated immunotherapy in AD
$494,300Rockefeller University · R01 · FY2001 · AG
Electron Spin Relaxation in Model Membranes
$494,276Jack H Freed · Cornell University · R01 · FY2018 · GM
Cortical Pathophysiology in Mouse Models of Huntington's Disease
$494,261Michael S. Levine · University Of California Los Angeles · R01 · FY2017 · NS
Electron Spin Relaxation in Model Membranes
$494,236Jack H Freed · Cornell University · R01 · FY2019 · GM
Electron Spin Relaxation in Model Membranes
$494,198Jack H Freed · Cornell University · R01 · FY2020 · GM
Circulating MicroRNAs and TLR8 Activation in Chronic Pain
$494,131Asma A Khan · Univ Of North Carolina Chapel Hill · R56 · FY2015 · DE
Environmental copper exposure and its impact on microglial Abeta clearance
$493,959Masashi Kitazawa · University Of California-Irvine · R01 · FY2017 · ES
Manipulating autophagy in human neurons to determine subtype-specific neurodegenerative disease phenotypes
$493,900Lorenz P. Studer · Sloan-Kettering Inst Can Research · R21 · FY2020 · NS
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION
$493,862Buck Institute For Age Research · R01 · FY2003 · AG
Role of PS1 in neurodegeneration
$493,699Oksana Berezovska · Massachusetts General Hospital · R01 · FY2018 · AG
Regulation of BACE1 by trophic factor signaling
$493,536Moses Victor Chao · New York University School Of Medicine · R56 · FY2018 · AG
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2016 · NS
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2015 · NS
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$493,335Stefan M. Pulst · University Of Utah · R37 · FY2017 · NS
Use of C. elegans as a model to study aging-associated neurodegeneration
$493,267Dong Yan · Duke University · R01 · FY2024 · AG